Sutimlimab improved hemoglobin and patient symptoms in cold agglutinin disease
1. Sutimlimab was shown to stop hemolysis, improve hemoglobin levels, and reduce patient fatigue in patients with cold agglutinin disease.
2, Infections and gastrointestinal adverse...
Pegcetacoplan improved hemoglobin levels in eculizumab-treated paroxysmal nocturnal hemoglobinuria patients
1. Pegcetacoplan was shown to reduce the change in hemoglobin level for the treatment of paroxysmal nocturnal hemoglobinuria compared to eculizumab.
2. Patients treated with...
